首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >TSPAN33 is a novel marker of activated and malignant B cells
【24h】

TSPAN33 is a novel marker of activated and malignant B cells

机译:TSPAN33是活化和恶性B细胞的新标记

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract We have identified Tspan33 as a gene encoding a transmembrane protein exhibiting a restricted expression pattern including expression in activated B cells. TSPAN33 is a member of the tetraspanin family. TSPAN33 is not expressed in resting B cells, but is strongly induced in primary human B cells following activation. Human 2E2 cells, a Burkitt's lymphoma-derived.B cell model of activation and differentiation, also upregulate TSPAN33 upon activation. TSPAN33 is expressed in several lymphomas including Hodgkin's and Diffuse large B cell lymphoma. TSPAN33 is also expressed in some autoimmune diseases where B cells participate in the pathology, including rheumatoid arthritis patients, systemic lupus erythematosus (SLE), and in spleen B cells from MRL/Fas~(lpr/lpr) mice (a mouse model of SLE). We conclude that TSPAN33 may be used as a diagnostic biomarker or as a target for therapeutic antibodies for treatment of certain B cell lymphomas or autoimmune diseases.
机译:摘要我们已经确定Tspan33为编码跨膜蛋白的基因,该蛋白表现出受限的表达模式,包括在活化B细胞中的表达。 TSPAN33是tetraspanin家族的成员。 TSPAN33在静止的B细胞中不表达,但是在激活后在原代人B细胞中被强烈诱导。人2E2细胞是伯基特氏淋巴瘤衍生的B细胞激活和分化模型,在激活时也会上调TSPAN33。 TSPAN33在几种淋巴瘤中表达,包括霍奇金氏和弥漫性大B细胞淋巴瘤。 TSPAN33还表达在某些B细胞参与病理的自身免疫疾病中,包括类风湿性关节炎患者,系统性红斑狼疮(SLE)以及MRL / Fas〜(lpr / lpr)小鼠的脾B细胞(SLE小鼠模型) )。我们得出的结论是,TSPAN33可用作诊断生物标志物或用作治疗某些B细胞淋巴瘤或自身免疫性疾病的治疗性抗体的靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号